Clinical Trials on Fatty Liver in Hong Kong

Total 458 results

The University of Hong Kong
Food and Health Bureau, Hong Kong

Completed

Effect of Empagliflozin on Liver Fat in Non-diabetic Patients

Non-alcoholic Fatty Liver Disease

Hong Kong
GenieBiome Limited

Completed

A Clinical Study to Evaluate the Effect of SIM01 in Female With NAFLD

Non-Alcoholic Fatty Liver Disease

Hong Kong
Humanity and Health Research Centre

Recruiting

Longitudinal Observational Study Of Chinese With NAFLD/NASH

Non-Alcoholic Fatty Liver Disease (NAFLD) | Non-Alcoholic Steatohepatitis (NASH)

Hong Kong
The University of Hong Kong

Active, not recruiting

Quantifying Steatosis in Liver Transplant Donors

Non-alcoholic Fatty Liver Disease | Evidence of Liver Transplantation

Hong Kong
The University of Hong Kong

Recruiting

Optimal Exercise Frequency to Reduce Liver Fat in Centrally Obese Adults With Non-Alcoholic Fatty Liver Disease

Obesity | Non-Alcoholic Fatty Liver Disease

Hong Kong
Hospital Authority, Hong Kong
The University of Hong Kong

Unknown

Non Alcoholic Fatty Liver Disease (NAFLD) in Hong Kong

Fatty Liver

China
Chinese University of Hong Kong

Completed

Low Glycemic Index Dietary Intervention Program in Nonalcoholic Fatty Liver Disease

Nonalcoholic Fatty Liver Disease

China
Chinese University of Hong Kong

Completed

Trial of Hepaguard® in Adults With Nonalcoholic Steatohepatitis

Nonalcoholic Fatty Liver Disease

China
The University of Hong Kong

Active, not recruiting

12-Month Once-a-week HIIT Improves Body Adiposity and Liver Fat

Non-Alcoholic Fatty Liver Disease | Central Obesity

Hong Kong
Chinese University of Hong Kong

Completed

Treatment of Nonalcoholic Fatty Liver Disease With Probiotics and Prebiotics

Nonalcoholic Fatty Liver Disease

China
Chinese University of Hong Kong

Recruiting

Monitoring Changes in Hepatic Steatosis Using Continuous Controlled Attenuation Parameter

Fatty Liver

Hong Kong
Chinese University of Hong Kong

Not yet recruiting

Simultaneous Quantification of Liver Fat Content, Fatty Acid Composition, and Fibrosis Using Spin-lock MRI for Steatohepatitis Assessment

Non-alcoholic Fatty Liver Disease (NAFLD) | Non-alcoholic Steatohepatitis (NASH)

Hong Kong
Chinese University of Hong Kong

Active, not recruiting

Identification of Fatty Liver With Advanced Fibrosis in Type 2 Diabetes Using Simple Fibrosis Scores and Electronic Reminder Messages

Diabetes Mellitus, Type 2 | Fatty Liver, Nonalcoholic

Hong Kong
Chinese University of Hong Kong

Terminated

Alternation of Non-alcoholic Fatty Liver Disease (NAFLD) and Cardiovascular Risks After Liftestyle Modification: A Ultrasound Attenuation Imaging-Based Study

Non-alcoholic Fatty Liver Disease

Hong Kong
Humanity and Health Research Centre

Recruiting

Follow-up of Chronic Hepatitis B Patients With Comorbid Nonalcoholic Fatty Liver Disease

Chronic Hepatitis B | Nonalcoholic Fatty Liver Disease

China
Chinese University of Hong Kong

Recruiting

Change of Adipose Tissues and Triglyceride After Bariatric Surgery or Life-style Intervention

Diabetes Mellitus | Insulin Resistance | Obesity, Morbid | Non-Alcoholic Fatty Liver Disease | Metabolic Disease | Brown Fat | Abdominal Subcutaneous Fat

Hong Kong
Chinese University of Hong Kong

Recruiting

Prevalence of Non-alcoholic Fatty Liver Disease Among Non-obese Obstructive Sleep Apnea by Using Transient Elastography

Sleep Apnea, Obstructive | Fatty Liver

Hong Kong
Chinese University of Hong Kong

Completed

Obstructive Sleep Apnoea and CPAP Treatment Response in Patients With Non-alcoholic Fatty Liver Disease

Obstructive Sleep Apnea | Non-alcoholic Fatty Liver Disease

Hong Kong
The University of Hong Kong
Innovation and Technology Commission, Hong Kong; Gense Technologies Ltd.

Recruiting

Electrical Impedance Tomography in Fatty Liver Detection

Non-Alcoholic Fatty Liver Disease

China
The University of Hong Kong
Gense Technologies Ltd.

Active, not recruiting

Ambulatory Liver Fat Monitoring in Patients With Non-alcoholic Fatty Liver Disease

Non-Alcoholic Fatty Liver Disease

China
Chinese University of Hong Kong

Recruiting

Lifestyle Modification Programme for HIV-infected Individuals With Fatty Liver

Hiv | NAFLD

Hong Kong
The University of Hong Kong

Recruiting

Smartphone App for Non-alcoholic Fatty Liver Disease (AppLiver)

Non-Alcoholic Fatty Liver Disease

China
Chinese University of Hong Kong

Recruiting

Determination of Pancreatic Steatosis Prevalence and Correlation With High-risk Cyst Features (FPPCN)

Pancreatic Cyst | Pancreatic Steatosis

Hong Kong
Humanity & Health Medical Group Limited

Recruiting

Immune Checkpoint Therapy vs Target Therapy in Reducing Serum HBsAg Levels in Patients With HBsAg+ Advanced Stage HCC

Hepatocellular Carcinoma

Hong Kong
Humanity & Health Medical Group Limited
Beijing 302 Hospital; Kindai University Faculty of Medicine

Terminated

Safety and Efficacy of Lenvatinib in Subjects With HCC Progression After First Line Treatment With Checkpoint Inhibitors

Hepatocellular Carcinoma

Hong Kong
The University of Hong Kong
Research Grant Council

Recruiting

Effects of Empagliflozin on Fibrosis and Cirrhosis in Chronic Hepatitis B

Cirrhosis | NAFLD | Chronic Hepatitis b | Fibrosis, Liver | Empagliflozin | SGLT2 Inhibitors

Hong Kong
The University of Hong Kong

Unknown

SBRT for Liver Cancer Before Liver Transplantation

Liver Cancer | Liver Transplant Disorder

Hong Kong
Chinese University of Hong Kong

Recruiting

The Impact of Fast-track Perioperative Program After Liver Resection in Hong Kong Chinese Patients

Liver Cancer

Hong Kong
The University of Hong Kong
Education University of Hong Kong

Recruiting

Artificial Intelligence vs. LIRADS in Diagnosing HCC on CT

HCC | Liver Cancer

Hong Kong
Humanity & Health Medical Group Limited

Completed

Antibody Response to COVID-19 Vaccines in Liver Disease Patients

Chronic Liver Disease

Hong Kong
The University of Hong Kong

Recruiting

Randomized Trial of Hepaticojejunostomy Versus Duct-to-duct Anastomosis in Right Lobe Living Donor Liver Transplantation

Liver Failure

Hong Kong
The University of Hong Kong

Recruiting

Clinical Outcome and Future Liver Remnant Regenerative Response in Laparoscopic Versus Open ALPPS

Liver Cancer

Hong Kong
Hoffmann-La Roche

Completed

A Study of Avastin (Bevacizumab) and Transarterial Chemoembolisation (TACE) Treatment in Patients With Liver Cancer

Liver Cancer

Hong Kong
Humanity & Health Medical Group Limited

Withdrawn

A Study to Evaluate Vaccines Against COVID-19 in the Real World

Chronic Liver Disease | Hepatic Carcinoma

Hong Kong
The University of Hong Kong

Completed

Frequent Ketamine Use and Gastrointestinal, Liver and Biliary Sequelae

Gastritis | Liver Fibrosis | Peptic Ulcer Disease | Cholangiopathy

Hong Kong
Chinese University of Hong Kong

Completed

A New Screening Strategy for Varices (LSSM-RCT)

Liver Cirrhosis

Hong Kong
Dr Tan-to CHEUNG

Completed

Neoadjuvant Anti-PD1 in HCC

HCC | Hepatocellular Carcinoma | Liver Cancer

Hong Kong
Chinese University of Hong Kong

Withdrawn

Three-Dimensional T1rho Using Spiral Fast Spin Echo

Liver Fibrosis

Hong Kong
Chinese University of Hong Kong

Terminated

A Study on the Angioarchitecture of Hepatocellular Carcinoma

Carcinoma, Hepatocellular

Hong Kong
Chinese University of Hong Kong

Recruiting

Development of Non-Invasive MRI Applications for Liver Fibrosis and Inflammation

Liver Fibrosis

Hong Kong
The University of Hong Kong

Recruiting

SBRT and Durvalumab for Inoperable/Unresectable Hepatocellular Carcinoma

Hepatocellular Carcinoma

Hong Kong
Chinese University of Hong Kong

Completed

Substudy: Interconnection of Arterial Tumor Feeders Through Tumor Sinusoid in HCC

Hepatocellular Carcinoma

Hong Kong
Chinese University of Hong Kong

Completed

Balloon Assisted Transarterial Therapy for Hepatocellular Carcinoma

Hepatocellular Carcinoma

Hong Kong
Chinese University of Hong Kong

Completed

Hepatocellular Carcinoma (HCC) Transarterial Chemoembolisation (TACE) +Axitinib

Hepatocellular Carcinoma

Hong Kong
Chinese University of Hong Kong

Terminated

Chemoembolization for Hepatocellular Carcinoma

Hepatocellular Carcinoma

Hong Kong
Bio-Cancer Treatment International Limited
The University of Hong Kong

Completed

Pegylated Recombinant Human Arginase 1 in Combination With Oxaliplatin and Capecitabine for the Treatment of HCC (PACOX)

Hepatocellular Carcinoma

Hong Kong
Bio-Cancer Treatment International Limited
The University of Hong Kong; Chinese University of Hong Kong

Completed

Study of Pegylated Human Recombinant Arginase for Liver Cancer (BCT-100-002) (BCT-100-002)

Hepatocellular Carcinoma | Neoplasm

Hong Kong
Hong Kong Children's Hospital

Recruiting

Ultrasound Measurements of Hepatic Vasculatures and Hepatic Doppler Assessment of Healthy Children

Portal Vein | Hepatic Veins | Hepatic Artery | Liver Circulation

Hong Kong
Chinese University of Hong Kong
Health and Medicine Research Fund

Recruiting

Laparoscopic Versus Open Major Hepatectomy for HCC Hepatectomy for Hepatocellular Carcinoma (AP-LAPO)

Hepatocellular Carcinoma

Hong Kong
Chinese University of Hong Kong
The Hong Kong Society of Gastroenterology

Completed

Cytokine Change in Hepatocellular Carcinoma Treated by Thermal Ablation

Hepatocellular Carcinoma

Hong Kong

Clinical Trials on Fatty Liver in Hong Kong

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Madagascar

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations